List of insiders holdings for Emergent BioSolutions Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
El-Hibri Fuad Director | 2021-12-07 21:10:11 | 1,136,971 3,706,442 | 4,843,413 | Form 4 |
Intervac L.L.C. 10% Owner | 2012-09-20 20:20:01 | 4,494,250 0 | 4,494,250 | Form 4 |
Microscience Investments LTD Member of 13(d) group 10% Owner | 2007-03-16 14:18:24 | 3,636,801 0 | 3,636,801 | Form 13G |
BIOPHARM L.L.C. 10% Owner | 2010-06-01 16:12:28 | 2,965,043 0 | 2,965,043 | Form 4 |
Myers Robert Calvin Member 13(d) group owning >10% | 2007-02-14 12:43:52 | 2,394,045 0 | 2,394,045 | Form 13G |
Biovac L.L.C. 13(d) group member, owns > 10% | 2007-02-14 12:30:52 | 1,599,155 0 | 1,599,155 | Form 13G |
JP MORGAN PARTNERS BHCA LP JP MORGAN PARTNERS GLOBAL INVESTORS LP J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN LP J P MORGAN PARTNERS GLOBAL INVESTORS A LP J P MORGAN PARTNERS GLOBAL INVESTORS CAYMAN II LP JP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN LLP JP MORGAN PARTNERS GLOBAL INVESTORS SELLDOWN II L P JPMP MASTER FUND MANAGER L P JPMP GLOBAL INVESTORS L P JPMP CAPITAL CORP Member of 13(d) group | 2007-03-19 11:32:58 | 1,454,418 0 | 1,454,418 | Form 3 |
Biologika L.L.C. Member 13(d) group owning >10% | 2008-06-06 18:11:33 | 1,399,764 0 | 1,399,764 | Form 4 |
Michigan Biologic Products Inc. Member 13(d) group owning >10% | 2008-03-28 20:17:57 | 1,269,390 0 | 1,269,390 | Form 4 |
Kramer Robert President and CEO | 2023-06-13 21:20:24 | 1,041,110 0 | 1,041,110 | Form 4 |
ADVENT PRIVATE EQUITY FUND III A LTD PARTNERSHIP Member of 13(d) Group | 2007-06-29 17:08:51 | 925,537 0 | 925,537 | Form 13G |
PAPA JOSEPH C President and CEO | 2024-03-15 17:16:43 | 750,000 0 | 750,000 | Form 4 |
Intervac Management L.L.C. 13(d) group member, owns > 10% | 2007-02-14 12:39:25 | 719,275 0 | 719,275 | Form 13G |
ARPI L.L.C. 13(d) group member, owns > 10% | 2007-02-14 12:20:25 | 658,254 0 | 658,254 | Form 13G |
Mulligan Seamus Director | 2019-03-21 16:18:12 | 56,141 545,590 | 601,731 | Form 4 |
Merlin General Partner II LTD (as General Partner of the Merlin Biosciences Fund L.P.) Member of 13(d) group | 2007-03-12 19:21:48 | 498,722 0 | 498,722 | Form 3 |
Havey Adam EVP, Business Operations | 2023-06-13 21:20:59 | 336,304 0 | 336,304 | Form 4 |
ADVENT PRIVATE EQUITY FUND III B LTD PARTNERSHIP Member of 13(d) Group | 2007-03-12 19:58:34 | 229,497 0 | 229,497 | Form 3 |
Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec | 2024-07-12 16:33:12 | 186,382 0 | 186,382 | Form 4 |
LINDAHL RICHARD S EVP, Chief Financial Officer | 2024-10-17 17:04:36 | 171,009 0 | 171,009 | Form 4 |
Glessner Coleen EVP, Quality & Ethics, and CPL | 2024-06-11 16:10:33 | 163,134 0 | 163,134 | Form 4 |
Fowler Neal Franklin Director | 2024-05-28 21:41:15 | 161,848 0 | 161,848 | Form 4 |
Abdun-Nabi Daniel CEO | 2019-03-04 18:39:36 | 142,617 1,936 | 144,553 | Form 4 |
SULLIVAN LOUIS W Director | 2024-05-28 21:14:55 | 130,443 0 | 130,443 | Form 4 |
ADVENT PRIVATE EQUITY FUND III D LTD PARTNERSHIP Member if a 13(d) Group | 2007-03-12 20:00:49 | 125,921 0 | 125,921 | Form 3 |
Arcuri Edward COO | 2007-05-10 11:04:35 | 115,083 0 | 115,083 | Form 4 |
Harsanyi Zsolt Chairman | 2024-05-28 21:14:42 | 115,077 0 | 115,077 | Form 4 |
DeGolyer Donald W Director | 2024-11-14 16:18:57 | 111,100 0 | 111,100 | Form 4 |
Richard Ronald Director | 2024-05-28 21:14:17 | 96,862 0 | 96,862 | Form 4 |
Dayal Sujata Tyagi Director | 2024-05-28 21:40:34 | 88,877 0 | 88,877 | Form 4 |
SARAN ATUL EVP, Chief Strat & Dev Officer | 2023-03-02 14:43:12 | 86,645 0 | 86,645 | Form 4 |
Katkin Keith Director | 2024-05-28 21:41:29 | 85,620 0 | 85,620 | Form 4 |
ADVENT PRIVATE EQUITY FUND III C LTD PARTNERSHIP Member of 13(d) Group | 2007-03-12 19:59:49 | 64,018 0 | 64,018 | Form 3 |
Strei Katherine EVP, Chief HR Officer | 2023-03-02 14:42:23 | 62,824 0 | 62,824 | Form 4 |
Hauer Jerome M Director | 2023-05-30 19:08:39 | 57,508 0 | 57,508 | Form 4 |
Zoon Kathryn C Director | 2024-06-06 16:16:20 | 54,482 0 | 54,482 | Form 4 |
White Marvin L Director | 2024-11-13 16:04:50 | 54,092 0 | 54,092 | Form 4 |
Hartzel William SVP, Bioservices | 2024-11-13 16:04:39 | 47,475 0 | 47,475 | Form 4 |
Perl Jessica SVP, General Counsel, Corp Sec | 2024-11-12 16:26:14 | 40,250 0 | 40,250 | Form 3 |
JOULWAN GEORGE A Director | 2022-05-31 16:20:57 | 40,244 0 | 40,244 | Form 4 |
Keese Kyle EVP, BioSciences Division | 2011-03-17 15:31:43 | 39,954 0 | 39,954 | Form 4 |
Elsey R Don Chief Financial Officer | 2012-03-16 15:06:13 | 38,914 0 | 38,914 | Form 4 |
Emergent BioSolutions Inc. Sean Kirk, EVP, Manufacturing | 2019-06-03 21:13:43 | 36,624 0 | 36,624 | Form 3 |
Niederhuber John Director | 2016-05-23 08:39:36 | 30,300 0 | 30,300 | Form 4/A |
Merlin General Partner II LTD (as Managing Partner of the Merlin Biosciences Fund Gbr) Member of 13(d) group | 2007-03-12 19:19:19 | 29,972 0 | 29,972 | Form 3 |
Chatfield Steven EVP, BioSciences | 2013-03-18 14:11:13 | 28,000 0 | 28,000 | Form 4 |
Esposito Denise CLO | 2009-03-12 14:38:00 | 27,300 0 | 27,300 | Form 4 |
Labinger Barry EVP, Biosciences Div. | 2015-11-17 17:15:40 | 25,182 0 | 25,182 | Form 4 |
Bailey Sue Director | 2021-03-08 18:30:56 | 24,427 0 | 24,427 | Form 4 |
Williams Paul Anthony SVP, Products Business | 2024-07-10 16:02:41 | 24,333 0 | 24,333 | Form 4 |
ADVENT PRIVATE EQUITY FUND III GMBH & CO KG Member of 13(d) Group | 2007-03-12 20:08:22 | 18,118 0 | 18,118 | Form 3 |
Kirk Sean EVP, Manufacturing & Tech Ops | 2021-04-01 18:54:16 | 17,776 0 | 17,776 | Form 4 |
ADVENT PRIVATE EQUITY FUND III AFFILIATES Member of 13 (d) Group | 2007-03-12 20:01:49 | 15,098 0 | 15,098 | Form 3 |
ALLBAUGH JOE M Director | 2008-05-23 10:13:49 | 14,400 0 | 14,400 | Form 4 |
Malik Shahzad Director | 2007-06-18 19:15:12 | 14,400 0 | 14,400 | Form 4 |
LOCKHART STEPHEN SVP Product Development | 2010-11-16 15:13:11 | 12,813 0 | 12,813 | Form 4 |
Smith Karen L. EVP, Chief Medical Officer | 2021-05-11 16:30:11 | 11,888 0 | 11,888 | Form 4 |
ADVENT MANAGEMENT III L P Member of 13(d) Group | 2007-03-12 20:07:21 | 4,530 0 | 4,530 | Form 3 |
Zink Thomas SVP & CMO | 2007-05-21 15:41:58 | 1000 0 | 1000 | Form 4 |
Lowry Simon C SVP, R&D, CMO | 2024-11-21 16:02:40 | 0 0 | 0 | Form 3 |
APAX EUROPE IV GP CO LTD Member of 13(d) group | 2008-10-17 11:12:09 | 0 0 | 0 | Form 13G |
Gibellini Mauro SVP, Corporate Dev. | 2007-06-06 15:10:32 | 0 0 | 0 | Form 4 |
MILLER H HAYWOOD III Interim CEO | 2023-07-18 18:22:14 | 0 0 | 0 | Form 3 |